JPS6366109A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPS6366109A JPS6366109A JP21009986A JP21009986A JPS6366109A JP S6366109 A JPS6366109 A JP S6366109A JP 21009986 A JP21009986 A JP 21009986A JP 21009986 A JP21009986 A JP 21009986A JP S6366109 A JPS6366109 A JP S6366109A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- acid
- cream
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 27
- 239000002253 acid Substances 0.000 claims abstract description 15
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 230000000694 effects Effects 0.000 abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 239000006071 cream Substances 0.000 abstract description 10
- 239000006210 lotion Substances 0.000 abstract description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 2
- 244000046052 Phaseolus vulgaris Species 0.000 abstract description 2
- 235000021332 kidney beans Nutrition 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- MAZWDMBCPDUFDJ-UHFFFAOYSA-N trans-Traumatinsaeure Natural products OC(=O)CCCCCCCCC=CC(O)=O MAZWDMBCPDUFDJ-UHFFFAOYSA-N 0.000 abstract 1
- MAZWDMBCPDUFDJ-VQHVLOKHSA-N traumatic acid Chemical compound OC(=O)CCCCCCCC\C=C\C(O)=O MAZWDMBCPDUFDJ-VQHVLOKHSA-N 0.000 abstract 1
- 238000009736 wetting Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 94
- 238000012360 testing method Methods 0.000 description 29
- 239000002884 skin cream Substances 0.000 description 23
- 210000000434 stratum corneum Anatomy 0.000 description 18
- 210000000245 forearm Anatomy 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 206010013786 Dry skin Diseases 0.000 description 15
- 230000037336 dry skin Effects 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 13
- 230000014759 maintenance of location Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 230000007306 turnover Effects 0.000 description 10
- 230000036074 healthy skin Effects 0.000 description 9
- 230000032683 aging Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 210000000736 corneocyte Anatomy 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000004299 exfoliation Methods 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- -1 alkali metal salts Chemical class 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004215 skin function Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical class NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 101150108455 Sil1 gene Proteins 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
Abstract
Description
【発明の詳細な説明】
(発明の分野)
本発明は、トラマチン酸および/またはその塩を配合し
てなる皮膚の水分保持機能を充進し得る皮膚化粧料に関
する。DETAILED DESCRIPTION OF THE INVENTION (Field of the Invention) The present invention relates to a skin cosmetic containing tramatic acid and/or a salt thereof, which can enhance the moisture retention function of the skin.
(従来技術)
従来より、健常な皮膚を保持する為に、皮膚に適度な水
分と油分を与える親水性の皮膚保湿剤と油性の皮膚柔軟
剤を皮膚化粧料に配合することが行われている。(Prior art) In order to maintain healthy skin, hydrophilic skin moisturizers and oily skin softeners that provide appropriate moisture and oil content to the skin have traditionally been blended into skin cosmetics. .
皮膚保湿剤には、グリセリン、プロピレングリコール、
ポリエチレングリコール、ピロリドンカルボン酸塩等が
利用されているが、これらは、皮膚の最外層である角質
層の水分を吸水して、かえって皮膚の水分を損失する原
因となることがあり、また、多量に含有する皮膚化粧料
にあっては、べたつくなどの異和感を与えるなど、必ず
しも満足出来るものではなかった。Skin moisturizers include glycerin, propylene glycol,
Polyethylene glycol, pyrrolidone carboxylate, etc. are used, but these may absorb water from the stratum corneum, the outermost layer of the skin, causing moisture loss in the skin, and they may also cause large amounts of water to be lost. However, skin cosmetics containing such substances have not always been satisfactory, such as giving an unpleasant feeling such as stickiness.
また、皮膚柔軟剤には、流動パラフィン、ワセリン、オ
リーブ油、スクアラン、ラノリン、合成エステル油等が
利用されているが、これらも、表皮よりの水分蒸散を充
分に防ぐ程度に皮膚化粧料に含有せしめるときには、皮
膚の正常なる新陳代謝を阻害する原因となるなどの欠点
を有していた。In addition, liquid paraffin, petrolatum, olive oil, squalane, lanolin, synthetic ester oil, etc. are used as skin softeners, but these are also included in skin cosmetics to the extent that they sufficiently prevent water evaporation from the epidermis. In some cases, they have the disadvantage of interfering with the normal metabolism of the skin.
(発明の開示)
本発明者等は、皮膚保湿剤、皮膚柔軟剤にみられる上記
の欠点に鑑み、それら配合剤の物理的作用による表皮へ
の水分補給あるいは表皮よりの水分蒸散防止のみに依存
するのではなく、皮膚が本来備えている水分保持機能を
亢進することによって皮膚を健常な状態に保持し、ある
いは修復するような皮膚化粧料を提供することを目的と
して鋭意研究した結果、トラマチン酸および/またはそ
の塩を配合してなる皮膚化粧料が該目的に合成ずる効果
を発現することを見出し、本発明を完成し7た。(Disclosure of the Invention) In view of the above-mentioned drawbacks of skin moisturizers and emollients, the present inventors have determined that they rely only on the physical action of these ingredients to replenish moisture to the epidermis or prevent water evaporation from the epidermis. As a result of intensive research with the aim of providing skin cosmetics that maintain or repair the skin in a healthy state by enhancing the skin's inherent moisture retention function, we found that tramatic acid The present invention has been completed based on the discovery that a skin cosmetic containing the compound and/or its salt exhibits a synthetic effect for the purpose.
皮膚の水分は、真皮から表皮の基底細飽層、更に角質層
へ1.と夕(層に向・)につれて成牛する水分金曜の勾
配に沿って、常に皮膚内部から外層部へ移動し、角質層
を通じて外部・\茎散1ッているが、この水分版数は十
に顆tri層頂部の層板顆粒から角質層乙こ及び緻密な
細胞組織からなる防御機能(ハリへ・−機能)により制
御されており、該芋敗量〔不感蒸711j (′l’r
ansepidermal Water l、oss)
値(以下、T W +、イーという)で表わされる〕は
例えば健常な皮膚のiE常な状態におげろ前腕部皮表で
は0.2〜0、3 +B / cm” / hrの範囲
、通常は0.25 mg / c+n2/11r稈度以
下に保↑JIされている。こねに対して、im常tこみ
こ)れる乾燥皮膚(トライスキン)あるいは老化皮膚に
シt)れる乾燥皮膚では、その程度に応じてT W L
(#はI−記の範囲の十−限値もしくはそれ、Lり大
きな値を示し、皮膚の水分保持機能が低下(−7でいる
ことが認められる。これはそれら乾燥皮膚の場合、角質
層の防御機能乙こよる通常の制御限界を超Aた状態にあ
るか、あるいは詩防御機11Lが衰えていることに由来
するものである。Water in the skin is transferred from the dermis to the basal saturated layer of the epidermis, and then to the stratum corneum.1. Along the gradient of moisture, which matures as the evening progresses, it always moves from the inside of the skin to the outer layer, passing through the stratum corneum to the outside. It is controlled by the protective function (firming function) consisting of the lamellar granules at the top of the granular layer, the stratum corneum, and the dense cell tissue, and the
ansepidermal Water l,oss)
For example, the iE of healthy skin (hereinafter referred to as T W +) is in the range of 0.2 to 0.3 + B/cm"/hr for the skin surface of the forearm under normal conditions, usually is kept below 0.25 mg/c+n2/11r culm degree↑JI.For dry skin (triskin) or aging skin, which is often crowded with kneading, T W L depending on the degree
(# indicates the tenth limit of the range listed in I, or a value larger than L, and the moisture retention function of the skin is decreased (-7). This is because in the case of dry skin, the stratum corneum This is due to the fact that the defense function is in a state that exceeds the normal control limit, or the poetry defense device 11L is weakening.
従って、角質層及び層板類FI′iの組織を緻密化し、
その防御機能を賦活することができれば1、−れによっ
て皮膚の水分保持機能が4.進され、皮膚は健常な状態
に保持されろ点共に、更ζ5二乾燥皮膚の改善ない1−
2は修復が可能となるのである。そこで、本発明者等は
、トラマチン酸;Ig貸よびイの塩の人皮膚に対する性
用効果に関1ッてtX 、*研究した結果、本発明の皮
膚化粧料が顆fr1層10部の層板顆粒から角質層に至
る組織を1常化1.、皮膚それ自体の水分保持機能を亢
進することにより、乾燥皮膚を改善し、あるいは皮膚を
健常な状態に保持してその老化を防ぎ、皮膚に湿潤性(
17,っとり感)、柔軟性(滑らか感)、弾力性及び艷
峻Jjえる美肌効果を有する、−とを見出した。Therefore, the structure of the stratum corneum and lamina FI'i is densified,
If this defense function can be activated, 1. The moisture retention function of the skin can be improved by 4. The skin is kept in a healthy condition, and it also improves dry skin.
2 can be repaired. Therefore, the present inventors conducted research on the sexual effects of tramatic acid; 1. Normalize the tissue from the plate granules to the stratum corneum. , improves dry skin by enhancing the skin's own moisture retention function, or maintains the skin in a healthy state to prevent aging, and provides moisture to the skin (
17. It has been found that it has a smooth skin feel), flexibility (smooth feeling), elasticity, and smooth skin effect.
本発明の皮膚化粧料の場合、従来の皮膚化粧料のごとく
前記の皮膚湿潤剤、皮膚柔軟剤を多Vに配合する必要が
なく、皮膚の正常な生理機能が防げられる虞れがない。In the case of the skin cosmetics of the present invention, unlike conventional skin cosmetics, there is no need to incorporate the above-mentioned skin moisturizers and skin softeners in large amounts, and there is no risk that the normal physiological functions of the skin will be prevented.
(発明の目的)
本発明の[」的は、皮膚が本来備えている水分保持機能
を亢進することによ、ツ°ζ皮膚を健常な状態に保持し
、或いは修復して、優れた美肌効果を有する皮膚化粧料
を提供するにある。(Objective of the Invention) The object of the present invention is to maintain or repair the skin in a healthy state by enhancing the skin's inherent moisture retention function, thereby achieving excellent skin beautification effects. The purpose of the present invention is to provide skin cosmetics having the following properties.
(発明の構成)
本発明は、1〜ラマチン酸および/またはその塩を配合
してなることを特徴とする皮膚化粧料に関するものであ
る。(Structure of the Invention) The present invention relates to a skin cosmetic containing 1 to llamatic acid and/or a salt thereof.
(構成のり、体的な説明)
本発明に用いる1ラマチン酸は、インゲンマメの幼果の
英に存在する細胞分留を誘起する活性をもつ物質であり
、豆科の植物を初めとして広く植物界に存在する。以I
Sにその特性値を列挙する。(Constituent glue, physical explanation) 1-Lamatic acid used in the present invention is a substance that has the activity of inducing cell fractionation, which is present in the young fruits of kidney beans, and is widely used in plants, including leguminous plants. exists in I
The characteristic values are listed in S.
化学名 : 2−1’デセンジオイ・ツクアシド(2−
rlodecenedioic acid>(Iloo
C(CIl□) eCH= CHCOOtl ’1化学
式 ’c1211211o4
分子璽 : 22B、28
性 状 ;白色粉末
融 点 : 166−167℃(t、 r a
n s体)溶解性 :水に非常に溶&)易く、エーテル
、ベンゼン、クロト1ホルムにiil y8また、トラ
マチン酸は、インゲンマメ等の豆Hの植物の幼果の莢に
多く存在し、植物を水またはアルコール、エーテル、ベ
ンゼン、クロI:1ホルJ4等の有機溶媒に浸し30〜
50℃に加温することで容易に抽出される。その抽出方
法に関してはプロシーディング・オブ・ナシqナルアカ
デミツクサイエンス、25巻323頁1939年(Pr
oc、。Chemical name: 2-1'desendioi tsuquaside (2-
rlodecenedioic acid>(Iloo
C (CIl
Solubility: Very soluble in water, easily dissolved in ether, benzene, and chloroform. Soak in water or an organic solvent such as alcohol, ether, benzene, Chloro I:1 hol J4, etc. for 30~
Easily extracted by heating to 50°C. Regarding its extraction method, see Proceedings of National Academic Science, Vol. 25, p. 323, 1939 (Pr.
oc,.
Nat、Acad、Sci、25,323+ 1939
) に記載されている。Nat, Acad, Sci, 25,323+ 1939
) It is described in.
本発明の皮膚化粧料中に配合されるトラマチン酸または
その塩は、表皮基底細胞の分裂を促進し皮膚機能を亢進
する効果を有する。更に皮膚の血行を促進し、皮膚本来
備えている機能を修復或は改善して、皮膚を健常な状態
に保持し、シー、とりとして滑かでかつ艶があり、きめ
の細かな所謂美肌の状態を維持する効果がある、−とが
認められる。Tramatic acid or its salt contained in the skin cosmetic of the present invention has the effect of promoting division of epidermal basal cells and enhancing skin function. Furthermore, it promotes blood circulation in the skin, restores or improves the skin's inherent functions, maintains the skin in a healthy state, and creates smooth, glossy, and finely textured skin. It is recognized that there is an effect of maintaining the condition.
特に老化皮膚に適用した場合にシl1、その効果が11
/i著に認められる。Sil1, its effectiveness is 11, especially when applied to aging skin.
Recognized by author /i.
本発明に使用し得る一ト記トラマチン酸の塩は、l・ラ
マチン酸と塩基とからなるモノ塩またはジ塩であって、
例えば、カリウム塩、ナトリウム塩等のアルカリ金属塩
、リジン塩、オルニチン塩、アルギニン塩等の塩基性ア
ミノ酸塩、モノエタノールアミン塩、トリエタノールア
ミン塩等のアルカノールアミン塩が挙げられる。The salts of tramatic acid that can be used in the present invention are monosalts or di-salts consisting of l-ramatic acid and a base,
Examples include alkali metal salts such as potassium salts and sodium salts, basic amino acid salts such as lysine salts, ornithine salts, and arginine salts, and alkanolamine salts such as monoethanolamine salts and triethanolamine salts.
本発明に於いて、トラマチン酸および/またはその塩の
配合量は、皮膚化粧料(組成物)の総量を基準として0
.01〜2重景%の範囲が好適である。配合量が0.0
1重量%未満では効果が充分に達成されず、一方2重景
%を超えてもその増加分に見合った効果の向上は望めな
い。In the present invention, the blending amount of tramatic acid and/or its salt is 0 based on the total amount of the skin cosmetic (composition).
.. A range of 0.01% to 0.02% is suitable. The amount added is 0.0
If the amount is less than 1% by weight, the effect will not be sufficiently achieved, while if it exceeds the double-viewing percentage, no improvement in the effect commensurate with the increase can be expected.
本発明の皮膚化粧料は、例えばローション類、乳液類、
クリーム類、パック類等に適用することができる。The skin cosmetics of the present invention include, for example, lotions, milky lotions,
It can be applied to creams, packs, etc.
尚、本発明の皮膚化粧料には上記の他に色素、香料、防
腐剤、界面活性剤、顔料、抗酸化剤等を本発明の目的を
達成する範囲内で適宜配合することができる。In addition to the above, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, and the like may be appropriately incorporated into the skin cosmetic of the present invention within a range that achieves the object of the present invention.
(実施例) 以下、実施例及び試験例に基づいて本発明を詳説する。(Example) Hereinafter, the present invention will be explained in detail based on Examples and Test Examples.
尚、T W L値、T W +−値値化化率角質層ター
ンオーバー速度、角質細胞の剥離特性の測定方法或いは
評価方法を下記に示した。The methods for measuring or evaluating the T W L value, T W +-value conversion rate, stratum corneum turnover rate, and exfoliation properties of corneocytes are shown below.
fllTWL値
密閉した皮表上の空気の一定時間内の湿度変化を電気抵
抗にて測定する方法を用いた。fllTWL value A method was used in which the humidity change in the air above the sealed skin surface within a certain period of time was measured using electrical resistance.
即ち、被試験者の皮表を測定用セルで密閉し、セルに強
制乾燥した空気を通気してセル内を乾燥空気で充分置換
した後、乾燥空気の通気を停市してその時点でのセル内
の相対湿度R+(s(%)を求め、次いで10分間放置
して再びセル内の相対湿度RH+o(%)を測定し、こ
の時の湿度変化から下記の式によりTWL値を算出した
。That is, the test subject's skin surface was sealed in a measurement cell, forced dry air was vented into the cell to fully replace the inside of the cell with dry air, and then the ventilation of dry air was stopped and the test was carried out at that point. The relative humidity R+(s (%)) inside the cell was determined, and then the relative humidity RH+o (%) inside the cell was measured again after being left for 10 minutes, and the TWL value was calculated from the humidity change at this time using the following formula.
但し、Dt=測定温度下(t ”c )での空気中の飽
和水蒸気の密度(mg/7り
V:セルの容積(7り
S:測定面積(cm2)
+21TWL値変化率
皮膚に試料(皮膚化粧料)を塗布する以前と以後におけ
るTWL値をそれぞれ求め、その変化率を下記の式より
算出し、TWL低減効果(水分保持機能亢進効果)を評
価した。However, Dt = Density of saturated water vapor in the air at the measurement temperature (t ''c ) (mg/7V: Volume of the cell (7S: Measurement area (cm2) +21 TWL value change rate Sample on the skin (skin) The TWL values before and after applying the cosmetic (cosmetics) were determined, and the rate of change was calculated using the following formula to evaluate the TWL reduction effect (moisture retention function enhancement effect).
試料(皮膚化粧料)塗布以前のT W L値: TW
L。T W L value before sample (skin cosmetic) application: TW
L.
試料(皮膚化粧料)塗布以後のTWl、値: TWL
A(3) 角質層のターンオーバー速度測定方法螢光
色素のダンジルクロライドを白色ワセリン中に5重量%
配合した軟膏を作り、被検者の前腕部の皮膚に24時間
閉塞貼布し、角質層にダンジルクロライドを浸透結合さ
せる。その後同じ部位に102回(朝・夕)被検試料を
塗布し、毎日ダンジルクロライドの螢光をしらべ、その
螢光が消滅するまでの日数を皮膚角質層のターンオーバ
ー速度とした。なお、通常の皮膚角質層のターンオ−バ
ー速度は14〜16日であるが、老化した皮膚において
は18日前後にのびる。それに対して老化防止効果が現
れると12日前後にまで短縮される。TWl after application of sample (skin cosmetic), value: TWL
A (3) Method for measuring the turnover rate of the stratum corneum 5% by weight of the fluorescent dye danzyl chloride in white petrolatum
A blended ointment is prepared and applied as an occlusive patch to the skin of the subject's forearm for 24 hours to allow danzyl chloride to penetrate and bind to the stratum corneum. Thereafter, the test sample was applied to the same area 102 times (morning and evening), and the fluorescence of danzyl chloride was examined every day.The number of days until the fluorescence disappeared was defined as the turnover rate of the skin stratum corneum. Note that the normal turnover rate of the stratum corneum of the skin is 14 to 16 days, but in aged skin, the turnover rate increases to around 18 days. On the other hand, if the anti-aging effect appears, the time will be shortened to around 12 days.
(4) 角質細胞の剥離特性
皮膚にスコッチテープにチハンメンディングテープ)を
貼付し、これを剥離して皮表の角質細胞をテープに付着
せしめた。次にこの角質細胞の状態を走査型電子顕微鏡
によって詳細に観察し、第1表に示す判定基準に基づい
て、角質細胞の剥離特性を分類してその指数を求めた。(4) Peeling characteristics of keratinocytes Scotch tape (chihan mending tape) was applied to the skin, and this was peeled off to allow the keratinocytes on the skin surface to adhere to the tape. Next, the condition of the keratinocytes was observed in detail using a scanning electron microscope, and the exfoliation characteristics of the keratinocytes were classified based on the criteria shown in Table 1, and their indices were determined.
第1表 角質細胞の剥離特性判定基準
造特性を判断する指標となるものであって、一般に乾燥
皮膚、老化皮膚に於ては、細胞間結合力が弱く、またそ
の構造の緻密性も低いことから指数が高くなることが確
認されている。Table 1: Judgment criteria for peeling properties of corneocytes.These serve as indicators for judging the building properties of corneocytes, and in general, in dry skin and aging skin, the intercellular bond strength is weak and the density of the structure is also low. It has been confirmed that the index increases from
実施例1〜3 比較例1
〔スキン クリーム〕
前記実験例で得たトラマチン酸および/またはその塩を
配合して本発明の実施例1〜3と比較例(11組 成
(重量%)
(2) 調製法
(A)成分及び(B)成分を各々80℃に加熱溶解した
1jk混合して、攪拌しつつ30℃迄冷却して各スキン
クリームを調製した。Examples 1 to 3 Comparative Example 1 [Skin Cream] Examples 1 to 3 of the present invention and Comparative Example (11 composition (wt%) (2 ) Preparation method Components (A) and (B) were heated and dissolved at 80°C and mixed together, and cooled to 30°C with stirring to prepare each skin cream.
試験例1
実施例1〜3の本発明のスキンクリーム及び比較例1の
スキンクリームを適用した際の、それらのT W L値
及び角質細胞剥離特性に及ぼす影響を調べた。Test Example 1 When the skin creams of the present invention of Examples 1 to 3 and the skin cream of Comparative Example 1 were applied, their effects on T W L value and keratin cell exfoliation properties were investigated.
(1) 試験方法
60名の健常な普通の皮膚の被試験者(年令20〜25
才の女性)を20名ずつ、3グループ(A、C及びEグ
ループ)に、また60名の通常の乾燥皮膚を示す被試験
者(年令20〜25才の女性)を20名ずつ、3グルー
プ(B、D及びFグループ
試験に先立ち全被試験者の左右前腕部皮表のT W L
値を測定し、各グループ毎に平均値を算出した。次に、
被試験者の前腕部皮表に、左前腕には全被試験者につい
て比較例1のスキンクリームを、また右前腕には、各グ
ループ毎にA及びBグループでは実施例1、C及びDグ
ループでは実施例2、E及びFグループでは実施例3の
各スキンクリームを、1日2回(朝、夕)連続1力月塗
布し、最終塗布口の翌日、全被試験者についてクリーム
を塗布した左右前腕部皮表部分のT W L値を測定し
、さらに角質細胞#I離時特性評価した。(1) Test method 60 healthy subjects with normal skin (age 20-25)
20 subjects (20 to 25 years old) were divided into 3 groups (groups A, C, and E), and 60 subjects (20 to 25 years old) with normal dry skin were divided into 3 groups (groups A, C, and E). Groups (B, D, and F) Prior to the test, T W L
The values were measured and the average value was calculated for each group. next,
The skin cream of Comparative Example 1 was applied to the skin surface of the forearm of the test subjects for all the test subjects on the left forearm, and the skin cream of Example 1 was applied to the right forearm of each group for groups A and B, and for groups C and D. In Example 2, E and F groups, each skin cream of Example 3 was applied twice a day (morning and evening) for one month continuously, and the cream was applied to all test subjects on the day after the final application. The T W L values of the skin surface areas of the left and right forearms were measured, and the time release characteristics of corneocytes #I were also evaluated.
尚、塗布試験終了後、医師により診断した結果では、全
被試験者の前腕部の皮膚及び体調に何ら異常は認められ
なかった。After the application test, a doctor diagnosed no abnormalities in the skin or physical condition of the forearm of any of the test subjects.
C21 結 果
スキンクリーム塗布前及び塗布後のTWL値それらTW
L値から求めたTWL値変化率並びに角質細胞剥離特性
の指数(何れの値も各グループ20名の平均値)を第2
表に示した。C21 Results TWL values before and after application of skin cream Those TW
The rate of change in TWL value obtained from the L value and the index of keratinocyte exfoliation properties (both values are the average value of 20 people in each group) were calculated as the second
Shown in the table.
第2表に示す結果より、下記の通り本発明の実施例1.
2及び3のスキンクリームの効果が認められた。From the results shown in Table 2, Example 1 of the present invention is as follows.
The effects of skin creams 2 and 3 were observed.
■ A,C及びEグループの健常な普通の皮膚に於ては
、元々皮膚の水分保持機能が正常な状態に保持されてい
るので、本発明のスキンクリーム(実施例1.2及び3
)塗布の効果は顕在化しにくい状況にあるが、それでも
、比較例1に比して若干の改善が認められる。■ In normal healthy skin of groups A, C, and E, the moisture retention function of the skin is originally maintained in a normal state.
) Although the effect of coating is difficult to become apparent, a slight improvement is still observed compared to Comparative Example 1.
■ B、D及びFグループの乾燥皮膚に於ては、本発明
のスキンクリーム(実施例1,2及び3)を塗布した右
前腕部皮表に、左前腕部皮表(比較例1のスキンクリー
ム)に比してTWL値の著しい改善が認められ、その値
は健常皮膚と同等か、もしくはそれに近づいている。本
発明のクリーム間の比較を行った場合、実施例3におい
て、水分保持機能改善効果が最も高く、次いで、実施例
2゜1の順であった。さらに、角質細胞剥離試験につい
ても同様な結果を得た。■ For dry skin in Groups B, D, and F, the skin surface of the right forearm to which the skin cream of the present invention (Examples 1, 2, and 3) was applied, and the skin surface of the left forearm (skin of Comparative Example 1) A significant improvement in the TWL value was observed compared to the cream), and the value was equal to or approaching that of healthy skin. When comparing the creams of the present invention, Example 3 had the highest moisture retention function improvement effect, followed by Example 2.1. Furthermore, similar results were obtained in the corneum cell peeling test.
即ち、本発明の実施例1,2及び3のスキンクリームは
、A、C並びにEグループにおいては健常な皮膚を保持
する効果を示し、また、B、D並びにFグループにおい
ては健常な皮膚に近付ける効果を有することは明らかで
ある。That is, the skin creams of Examples 1, 2, and 3 of the present invention showed the effect of maintaining healthy skin in groups A, C, and E, and also showed the effect of maintaining healthy skin in groups B, D, and F. It is clear that it has an effect.
これらの結果より、本発明の実施例1.2及び3のスキ
ンクリームに含まれるトラマチン酸および/またはその
塩が表皮細胞に有効に作用し、角質層の細胞間結合能力
を改善して、その構造を緻密にし、皮膚の水分保持機能
を凡退すること、及び健常な皮膚の生理機能はこれを何
ら阻害しない試験例2
実施例3の本発明のスキンクリーム及び比較例1のスキ
ンクリームについて、それらの健常な皮膚及び老化乾燥
皮膚のTWL値及び角質層ターンオーバー速度に及ぼす
影響を調べた。These results show that tramatic acid and/or its salts contained in the skin creams of Examples 1.2 and 3 of the present invention effectively act on epidermal cells, improve the intercellular bonding ability of the stratum corneum, and Test Example 2 The skin cream of the present invention of Example 3 and the skin cream of Comparative Example 1 have a dense structure, reduce the moisture retention function of the skin, and do not inhibit the physiological functions of healthy skin. The effects of 20% on the TWL value and stratum corneum turnover rate of healthy skin and aged dry skin were investigated.
(11試験方法
新たに、Gグループとして、健常なViiIlの皮膚の
被試験者20名(年令20〜25才の女性)、及びHグ
ループとして老化による乾燥皮膚を示す被試験者20名
(年令50〜60才の女性)の計40名について、予め
左右前腕部皮表のTWL値を測定した後、左右前腕部に
ダンジルクロライド含有軟膏を24時間閉塞貼布した。(11 Test method) We newly added 20 test subjects (women aged 20 to 25 years old) with healthy ViiI skin as G group, and 20 test subjects with dry skin due to aging as H group (20 test subjects with dry skin due to aging) as G group. For a total of 40 women aged 50 to 60 years old, the TWL values on the skin surfaces of the left and right forearms were measured in advance, and ointment containing danzyl chloride was applied to the left and right forearms for 24 hours.
次に、G及び■グループの全被試験者の左前腕部皮表に
比較例1のスキンクリームを、また右前腕部皮表には実
施例1のスキンクリームを各々1日2回(朝、夕)連続
1力月塗布し、毎日、その螢光を調べた。最終塗布口の
翌日、全被試験者について、クリームを塗布した左右前
腕部皮表部分のTWL値を測定した。Next, the skin cream of Comparative Example 1 was applied to the skin surface of the left forearm of all the test subjects in Groups G and ■, and the skin cream of Example 1 was applied to the skin surface of the right forearm twice a day (in the morning, Evening) The solution was applied continuously for one month, and the fluorescence was examined every day. On the day after the final application, the TWL values of the skin surface areas of the left and right forearms to which the cream was applied were measured for all test subjects.
尚、塗布試験終了後、医師による診断結−甲で15よ、
全被試験者の曲腕部の皮膚及び体調に何ら異常は認めら
れなかった。In addition, after the completion of the application test, the doctor will give a diagnosis of 15.
No abnormalities were observed in the skin or physical condition of the bent arms of any of the subjects.
(2) 結 果
スキンクリーム塗布前及び塗布後のT W L 4直(
各グループ20名の平均値)1、それら1” W 1−
1値から求めたT W L、値化化率並びに角質層ター
ンオーバー速度(各グループ20名の平均イ直)を第3
第3表に示す結果より、下記の通り本発明の実施例3の
スキンクリームの効果が認められた。(2) Results T W L 4 shifts before and after skin cream application (
Average value of 20 people in each group) 1, those 1” W 1-
The T W L, value conversion rate, and stratum corneum turnover rate (average value of 20 people in each group) calculated from the 1 value were calculated in the third
From the results shown in Table 3, the effects of the skin cream of Example 3 of the present invention were recognized as follows.
0)Gグループの健常な普通の皮膚に於ては、皮膚の機
能状況が、正常に保持されていることから、本発明のス
キンクリーム(実施例3)により角質層ターンオーバー
速用の亢進は認められなかった。0) In the healthy normal skin of group G, the skin function status is maintained normally, so the skin cream of the present invention (Example 3) does not increase the turnover rate of the stratum corneum. I was not able to admit.
また、′T’ W L稙乙こついては、試験例1と同様
な結 1果を得た。
!■ 11グループの老化乾燥皮膚に於ては
、本発明のスキンクリーム(実施例3)を塗布した右前
腕部皮表に、左前碗部皮表(比較例1のスキンクリ
゛−ム塗布)に比して、角質層ターンオーバー速度の冗
iff (短縮化)が認められ、その値は正常皮膚の値
に近付くものであった。T W L値については、
r試験例1の通常の乾燥皮膚で認められたと同様に
(本発明のクリーム(実施例3)塗布により、著しい改
N(TWl、値の低下)を示し、正常人の値と同等か、
もしくは、その値に近付くものである。In addition, the same results as in Test Example 1 were obtained for 'T'WL.
! ■ For aged dry skin in Group 11, the skin surface of the right forearm to which the skin cream of the present invention (Example 3) was applied was applied, and the skin surface of the left forearm area (the skin cream of Comparative Example 1) was applied.
A reduction in the turnover rate of the stratum corneum was observed as compared to the application of a cream, and the value approached that of normal skin. Regarding the T W L value,
rSimilar to what was observed in normal dry skin in Test Example 1
(The application of the cream of the present invention (Example 3) showed a significant decrease in N (TWl, value), and the value was equivalent to that of a normal person.
Or something close to that value.
1!11ち、本発明の実施例1のスキンクリームは、老
化乾燥皮膚の角質層ターンオーバー速度を健常直皮膚の
ものに近付+)、■つ、水う)保持機能を高6るものと
言える。1!11 The skin cream of Example 1 of the present invention brings the turnover rate of the stratum corneum of aging dry skin close to that of healthy skin, and has a high water retention function. I can say that.
試験例3
比較例1及び実施例1〜3のスー1−ンクリームをり燥
皮膚を訴える被試験者各々30名(2(1〜34才の女
性)に1日2回(朝、夕)連続1力月11塗布した。医
師による診断の結果では、全被試禽者の皮膚及び体調に
異常は認められなかった。Test Example 3 The creams of Comparative Example 1 and Examples 1 to 3 were applied twice a day (morning and evening) to 30 test subjects (2 females aged 1 to 34 years) who complained of dry skin. The drug was applied for 11 consecutive months.As a result of the diagnosis by a doctor, no abnormality was observed in the skin or physical condition of all the birds tested.
クリームを塗布した後の皮膚に湿潤i’l (L、っと
〕感)、柔軟性(滑らか感)、弾力性及び艷を与しる効
果を全被試験者について調査した結果を第1表に示した
。Table 1 shows the results of a survey conducted on all test subjects to determine the effect of imparting moisturized (L) feeling, softness (smooth feeling), elasticity, and elasticity to the skin after applying the cream. It was shown to.
第4表の結果から明らかなごとく、l・ラマ千ン貸およ
び/またはその塩を含イjする実施例1〜3リスキンク
リームは比較例1のスキンクリームに第 4
表
実施例4〜5、比較例2
〔スキンローション(二層型)〕
実施例1と同様に前記実験例で得たステロールグルコシ
ドを配合して各スキンローションを調製し、諸試験を実
施した。As is clear from the results in Table 4, the risk skin creams of Examples 1 to 3 that contain l.
Table Examples 4 to 5, Comparative Example 2 [Skin lotion (two-layer type)] In the same manner as in Example 1, each skin lotion was prepared by blending the sterol glucoside obtained in the above experimental example, and various tests were conducted.
(2) 調製法
成分(A)、(B)を各々均一に溶解した後、成分(A
)と成分(B)を混合撹拌分散し、次いで容器に充填す
る。(2) Preparation method After uniformly dissolving components (A) and (B),
) and component (B) are mixed, stirred and dispersed, and then filled into a container.
使用時には内容物を均一に振盪分散して皮膚に塗布する
。When using, shake and disperse the contents evenly and apply to the skin.
試験例4
比較例2および実施例4〜5のスキンローションを乾燥
皮膚を訴える被試験者各30名(年令26〜34才の女
性)に1日2回(朝、夕)連続1ケ月間塗布した。医師
による診断の結果では、全被試験者の皮膚および体調に
異常は認められなかった。Test Example 4 The skin lotions of Comparative Example 2 and Examples 4 to 5 were administered twice a day (morning and evening) for one consecutive month to 30 test subjects (women aged 26 to 34 years old) who complained of dry skin. Coated. Diagnosis by a doctor revealed no abnormalities in the skin or physical condition of all test subjects.
次にスキンローションを塗布した後の皮膚に湿潤性(し
っとり感)、柔軟性(滑らか感)、弾力性および艷を与
える効果を全被試験者について調査した結果を第5表に
示した。Next, Table 5 shows the results of an investigation on all test subjects regarding the effect of imparting moisture (moist feeling), flexibility (smooth feeling), elasticity, and elasticity to the skin after applying the skin lotion.
第 5 表
第5表の結果から明らかなように、本発明の実施例4〜
5のスキンローションはいずれも比較例2よりもすぐれ
た結果を示すが、特に実施例5のスキンローションの場
合に顕著な皮膚改善効果が認められる。Table 5 As is clear from the results in Table 5, Examples 4 to 4 of the present invention
All of the skin lotions of Example 5 show better results than Comparative Example 2, but especially the skin lotion of Example 5 shows a remarkable skin improvement effect.
(発明の効果)
本発明のl・ラマチン酸および/またはその塩を配合し
ζなる皮膚化粧料は、皮膚が本来備えている水分保持機
能をA−進することによって、皮膚を健常な状態に保持
し或いは修復して皮膚に湿潤性、柔軟性、弾力性及び艶
を与え、優れた美肌効果を有する皮膚化粧料を提供する
ものである。(Effects of the Invention) The skin cosmetics of the present invention containing l-lamatic acid and/or its salt maintain the skin in a healthy state by promoting the skin's inherent moisture retention function. The object of the present invention is to provide a skin cosmetic that maintains or repairs the skin, imparts moisture, flexibility, elasticity, and luster to the skin, and has an excellent skin beautifying effect.
Claims (1)
を特徴とする皮膚化粧料。A skin cosmetic comprising tramatic acid and/or a salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61210099A JPH0723296B2 (en) | 1986-09-05 | 1986-09-05 | Skin cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61210099A JPH0723296B2 (en) | 1986-09-05 | 1986-09-05 | Skin cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6366109A true JPS6366109A (en) | 1988-03-24 |
JPH0723296B2 JPH0723296B2 (en) | 1995-03-15 |
Family
ID=16583798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61210099A Expired - Fee Related JPH0723296B2 (en) | 1986-09-05 | 1986-09-05 | Skin cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0723296B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1093786A1 (en) * | 1999-10-21 | 2001-04-25 | Coreana Cosmetics Co., Ltd. | Skin cosmetic composition containing kidney bean extracts |
KR100447825B1 (en) * | 2001-11-23 | 2004-09-08 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Traumatic Acid for Enhancing Collagen Biosynthesis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3542826A (en) * | 1968-03-22 | 1970-11-24 | Purex Corp Ltd | Cobalt dodecenedioate and use thereof |
US3720773A (en) * | 1970-01-22 | 1973-03-13 | Purex Corp Ltd | Method and composition for the topical treatment of herpetic keratitis |
US3808314A (en) * | 1970-01-22 | 1974-04-30 | Purex Corp Ltd | Cobalt dodecenedioate for treating canine pyometritis |
US3814804A (en) * | 1970-01-22 | 1974-06-04 | Purex Corp Ltd | Use of cobalt dodecenedioate for treating skin conditions |
-
1986
- 1986-09-05 JP JP61210099A patent/JPH0723296B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3542826A (en) * | 1968-03-22 | 1970-11-24 | Purex Corp Ltd | Cobalt dodecenedioate and use thereof |
US3720773A (en) * | 1970-01-22 | 1973-03-13 | Purex Corp Ltd | Method and composition for the topical treatment of herpetic keratitis |
US3808314A (en) * | 1970-01-22 | 1974-04-30 | Purex Corp Ltd | Cobalt dodecenedioate for treating canine pyometritis |
US3814804A (en) * | 1970-01-22 | 1974-06-04 | Purex Corp Ltd | Use of cobalt dodecenedioate for treating skin conditions |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1093786A1 (en) * | 1999-10-21 | 2001-04-25 | Coreana Cosmetics Co., Ltd. | Skin cosmetic composition containing kidney bean extracts |
KR100447825B1 (en) * | 2001-11-23 | 2004-09-08 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Traumatic Acid for Enhancing Collagen Biosynthesis |
Also Published As
Publication number | Publication date |
---|---|
JPH0723296B2 (en) | 1995-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109350591B (en) | Dry facial mask for beautifying face and preparation method thereof | |
JP2010504299A (en) | Cosmetic use of active agents that stimulate matriptase expression | |
JPS61271205A (en) | Skin cosmetic | |
WO2018074642A1 (en) | Cosmetic composition for protecting lips, containing natural ceramides and rosehip oil as active ingredients | |
CN112370408B (en) | Composition with high moisturizing effect and application thereof in cosmetics | |
JP2511820B2 (en) | Skin cosmetics | |
JPS61286307A (en) | Skin cosmetic | |
JPS6366109A (en) | Skin cosmetic | |
JPS63159304A (en) | Skin cosmetic | |
JP5855949B2 (en) | Keratin production promoter, hair dye and nail polish | |
JPS6272604A (en) | Skin cosmetic | |
KR20000055724A (en) | Moisturizing cosmetic compositions containing a beta-1,6-branched-beta-1,3-glucan | |
JPS60161911A (en) | Skin cosmetic | |
JPS6377809A (en) | Skin cosmetic | |
KR102213809B1 (en) | Cosmetic composition containing starfish collagen and Viburnum erosum fruit extract for moisturizing and firming the skin | |
JP2511817B2 (en) | Skin cosmetics | |
CN116139060B (en) | Composition with anti-inflammatory and anti-aging effects and preparation method and application thereof | |
KR0153203B1 (en) | Cosmetic composition for moisturising and softening | |
JP2702754B2 (en) | Skin cosmetics | |
JPS62153206A (en) | Skin cosmetic | |
JPS6229507A (en) | Skin cosmetic | |
CN115887317A (en) | Moisturizing composition and moisturizing liquid for skin | |
JPS6366108A (en) | Skin cosmetic | |
RU2007163C1 (en) | Agent for washing head and body | |
JPH0692290B2 (en) | Skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |